Search results
...As Weight Loss Drug Only Wealthy People Can Afford - Novo Nordisk (NYSE:NVO), Eli Lilly and Co...
Benzinga· 2 days agoTesla and SpaceX CEO Elon Musk made a bold prediction about the future cost of Novo Nordisk’s NVO...
The Zacks Analyst Blog Highlights Microsoft, Eli Lilly, Costco and Koss
Zacks via Yahoo Finance· 6 days agoMSFT, Eli Lilly and Co. LLY, Costco Wholesale Corp. COST, Koss Corp. KOSS. Top Research...., Eli...
Stocks to Watch Friday: Workday, Intuit, Nvidia, Deckers Outdoor
The Wall Street Journal· 2 days ago**Nvidia (NVDA)**: The chip maker's stock edged upward Friday. It closed at a record high Thursday...
Stocks to Buy: 7 Undeniable Dow Darlings to Pile Into Now
InvestorPlace· 2 days agoInvesting in Dow stocks is always a reasonable strategy for those who value the American economy....
What are active managers doing these days? Buying AI says BofA
Investing.com via Yahoo Finance· 2 days agoThis trend is further supported by a positive correlation between the number of "AI" mentions on earnings calls and the change...According to BofA’s team, the company’s post-earnings 10% jump ...
S&P 500 today: SPX is up 11.77% today
USA Today· 6 days agoThe S&P 500 opened today at 5,303.94. Within 30 minutes of trading, the benchmark index rose by 17.80 points, or 0.34%, to 5,321.74. Year to date, the...
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
CNBC· 5 days agoA patient injects herself with an insulin pen. The rivalry between Eli Lilly and Novo Nordisk...
Hims & Hers Health Stock Jumps Nearly 28% on Plans to Offer GLP-1 Weight-Loss Drugs
Investopedia· 7 days agoThe rising popularity of GLP-1 weight-loss drugs has helped drive Eli Lilly and Novo Nordisk's...
3 S&P 500 Stocks to Buy in May Before They Rocket Higher
InvestorPlace· 5 days agoThe market is full of prominent stocks, but certain S&P 500 stocks rarely disappoint. Without...
This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan...
Benzinga· 5 days agoThe Structure Therapeutics GPCR stock has been identified as a potential winner in the obesity drug...